drugset / Trial / NCT06887010

A Study to Assess How Food Affects the Movement of Oral ABBV-101 Through the Body of Healthy Adult Participants

NCT06887010 ↗

Phase 1 Completed 17 enrolled AbbVie
RandomizedCrossoverOpen-labelBasic science

Summary

This study will assess the effect of food (high fat) on oral ABBV-101 and how ABBV-101 moves through the body in healthy adult participants

Timeline

Start
2025-03-25
Primary completion
2025-09-16
Completion
2025-09-16

Drugs

EvaluationDrugModalityDoseRoute
Subject ABBV-101 Other / unclassified — Oral

Indications

No indication recorded.